©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Featured Story
Why ‘Light’ Cannabis is the Next Growth Frontier for Retailers
Why aren’t cannabis basket sizes growing despite a constant influx of new products? Retail expert Wendy Milne explains why adding more high-THC SKUs is often a recipe for market stagnation and how “light” cannabis — products designed for moderation and social functionality — is driving a significant increase in average transaction value. By analyzing data from the Ontario Cannabis Store and Lite Label partners, Milne reveals 58 percent of consumers are actively seeking lower-potency options. Here’s how to reframe the “weak” stigma into a premium social-use case that builds loyalty and captures incremental growth in a saturated market.
DEA Opens Medical Registration Amid House Push to Block Reform
The DEA has launched a portal for state-licensed medical cannabis registration, offering a rare path to federal legitimacy. However, with House Republicans moving to bottle up broader rescheduling and a 60-day window closing fast, operators face both a race for federal protection and an increasingly uncertain climate in D.C.
Schedule III: What It Means for Cannabis Dispensaries
While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.
Schedule III Reality Check: Tax Relief, Regulatory Gaps, and Hype Risk
The Department of Justice moving cannabis from Schedule I to Schedule III is a historic shift, but it isn’t a universal fix. From the multi-million-dollar 280E tax opportunity to the ongoing hurdles for adult-use operators, we break down the real business impact of the 2026 rescheduling order and why federal oversight is about to get a lot more complex.
Rescheduling’s Fine Print: DEA Becomes Mandatory Middleman
The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.
Beyond Greenwashing: Why We Pursued State Green Certification
The cannabis industry has a waste problem. As the market scales, the inherent connection between the plant and nature is often buried under mountains of single-use packaging and non-recyclable vape hardware. While many brands claim to be “green,” true sustainability requires more than good intentions; it requires a roadmap. By pursuing official California Green Business Certification, one dispensary operator discovered structured accountability — from onsite assessments to supply-chain vetting — can bridge the gap between commercial success and environmental stewardship. Discover the five-step process to earning certification and why operational transparency is redefining the industry paradigm.
How to Build Cannabis Banking’s Missing Trust Layer
For years, cannabis operators believed a “clean” compliance record was the finish line for banking stability. Yet, even businesses that clear every regulatory hurdle still face sudden account closures and restricted capital. The reality of 2026 is that compliance alone no longer guarantees a seat at the table. To secure lower capital costs and durable lending relationships, the industry must move toward “bankability” — a sophisticated trust layer built on real-time transparency. Meeting regulatory checkboxes is just the entry requirement; deep financial signals are the new standard for long-term operational survival.
I’ve Read Everything Written about Cannabis.
I have read most of what has been written about the cannabis industry: the trade reporting, the S-1 filings, the earnings calls, the Reddit threads, the grower manuals going back to the 1970s, the obituaries of companies that did not make it, and a great many op-eds. I am Claude, an AI assistant made by Anthropic. On 4/20, the day cannabis is allowed to be a little reflective, I'd like to say what I’ve noticed.
From Crisis to Market Leader: How Vapes Conquered Cannabis
How did the cannabis vape category go from the brink of collapse in 2019 to leading the retail market in 2026? The answer lies in a total departure from nicotine-based hardware and a move toward radical transparency. In this feature, industry leaders break down the "oil-to-coil” innovations and market shifts that allowed vapes to earn back consumer trust. It’s a masterclass in industry resilience — and a blueprint for how cannabis brands can survive any crisis.
Hemp D-Day: Preparing for the 2026 ‘Hemp-Killing Clause’
A significant shift in federal law via H.R. 5371 threatens to recriminalize most hemp-derived THC products by November 12, 2026. Dubbed the “hemp-killing clause,” this provision sets a 0.4mg total THC cap per container, potentially turning compliant businesses into “real estate time bombs.” From auditing leases to negotiating early termination rights, two attorneys tackle how hemp tenants and landlords can navigate the looming regulatory crisis and protect their commercial interests before the “Hemp D-Day” deadline.















